Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy in Denmark and 5-Year Projections
Benjamin Sommer Thinggaard, Frederik Nørregaard Pedersen, Jakob Grauslund, Lonny Stokholm
Abstract
This cohort study examines the use of intravitreal injections of vascular endothelial growth factor inhibitor in Denmark from 2007 through 2022 and forecasts future demand for this therapy.
Topics & Concepts
Vascular endothelial growth factorMedicineCohortVEGF receptorsInternal medicineRetinal Diseases and TreatmentsRetinal and Optic ConditionsOcular Oncology and Treatments